Enamine | Partner Brands | Drug Screen
Website: http://www.enamine.net
Enamine was established in 1991 and has been committed to high-throughput screening for early drug development since its establishment. With the rapid increase in demand for new compounds, the company has also developed rapidly. In the past 20 years, Enamine has become a global supplier of screening compounds, block compounds, and fragment compounds, providing corresponding support for research programs of global pharmaceutical and biotechnology companies, academic institutions, and other research and development institutions.
Over the years, Enamine has developed a comprehensive set of research and development services to meet the growing needs of customers. Enamine supports the provision of various pharmaceutical chemistry services, including customized synthesis, compound library design, hit compound tracking, and lead compound optimization.
Enamine is committed to providing one-stop solutions for the life sciences industry to meet various research needs. Enamine is headquartered in Kiev, Ukraine, covering an area of 5 acres and has multiple buildings for chemical and analytical laboratories, composite raw material facilities, operations, and business departments. The company has several inventory factories in the United States and Europe, and works through authorized representatives in the Asian region.
